Literature DB >> 20444889

Adenovirus late-phase infection is controlled by a novel L4 promoter.

Susan J Morris1, Gillian E Scott, Keith N Leppard.   

Abstract

During human adenovirus 5 infection, a temporal cascade of gene expression leads ultimately to the production of large amounts of the proteins needed to construct progeny virions. However, the mechanism for the activation of the major late gene that encodes these viral structural proteins has not been well understood. We show here that two key positive regulators of the major late gene, L4-22K and L4-33K, previously thought to be expressed under the control of the major late promoter itself, initially are expressed from a novel promoter that is embedded within the major late gene and dedicated to their expression. This L4 promoter is required for late gene expression and is activated by a combination of viral protein activators produced during the infection, including E1A, E4 Orf3, and the intermediate-phase protein IVa2, and also by viral genome replication. This new understanding redraws the long-established view of how adenoviral gene expression patterns are controlled and offers new ways to manipulate that gene expression cascade for adenovirus vector applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444889      PMCID: PMC2898241          DOI: 10.1128/JVI.00107-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Control of adenovirus major late gene expression at multiple levels.

Authors:  S Larsson; C Svensson; G Akusjärvi
Journal:  J Mol Biol       Date:  1992-05-20       Impact factor: 5.469

2.  Regulation of the biosynthesis of subgroup C adenovirus protein IVa2.

Authors:  N Winter; J C D'Halluin
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Sequence-specific activation of transcription by adenovirus EIa products is observed in HeLa cells but not in 293 cells.

Authors:  T Leff; P Chambon
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

4.  Redundant control of adenovirus late gene expression by early region 4.

Authors:  E Bridge; G Ketner
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Late nonstructural 100,000- and 33,000-dalton proteins of adenovirus type 2. I. Subcellular localization during the course of infection.

Authors:  C Gambke; W Deppert
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

6.  Controls of RNA splicing and termination in the major late adenovirus transcription unit.

Authors:  G Akusjärvi; H Persson
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

7.  Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing.

Authors:  J R Nevins; M C Wilson
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

8.  Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein.

Authors:  N C Reich; P Sarnow; E Duprey; A J Levine
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

9.  In vivo identification of multiple promoter domains of adenovirus EIIA-late promoter.

Authors:  G Bhat; L SivaRaman; S Murthy; P Domer; B Thimmappaya
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

10.  Two functions encoded by adenovirus early region 1A are responsible for the activation and repression of the DNA-binding protein gene.

Authors:  R A Guilfoyle; W P Osheroff; M Rossini
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  21 in total

1.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

2.  Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genome.

Authors:  Baoling Ying; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  The adenovirus L4-33K protein regulates both late gene expression patterns and viral DNA packaging.

Authors:  Kai Wu; Diana Guimet; Patrick Hearing
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

4.  The adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome.

Authors:  Diana Guimet; Patrick Hearing
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

5.  Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.

Authors:  Mallory A Turner; Sumit Middha; Sean E Hofherr; Michael A Barry
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

6.  E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.

Authors:  Paloma Hidalgo; Yasel Garcés; Eduardo Mundo; Raúl E López; Luca D Bertzbach; Thomas Dobner; Ramón A González
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

7.  Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells.

Authors:  Paloma Hidalgo; Ramón A Gonzalez
Journal:  J Vis Exp       Date:  2015-11-12       Impact factor: 1.355

8.  Promyelocytic leukemia protein isoform II inhibits infection by human adenovirus type 5 through effects on HSP70 and the interferon response.

Authors:  Zeenah Atwan; Jordan Wright; Andrew Woodman; Keith N Leppard
Journal:  J Gen Virol       Date:  2016-05-23       Impact factor: 3.891

9.  Generation of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange.

Authors:  Susan J Morris; Daniel C Farley; Keith N Leppard
Journal:  BMC Biotechnol       Date:  2010-12-23       Impact factor: 2.563

Review 10.  Chromatin structure of adenovirus DNA throughout infection.

Authors:  Andrea N Giberson; Adam R Davidson; Robin J Parks
Journal:  Nucleic Acids Res       Date:  2011-11-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.